Arcadia Specialty Genomics

Arcadia Specialty Genomics was a strategic business unit of Arcadia Biosciences focused on the genetic optimization and standardization of hemp. Launched in 2019 following the passage of the U.S. Farm Bill, the division utilized advanced breeding technologies such as CRISPR and TILLING to develop hemp varieties with improved yield, pest resistance, and specific cannabinoid profiles. The company's primary goal was to provide high-quality, federally compliant hemp seeds and extracts for the nutraceutical and pharmaceutical markets, specifically targeting CBD production. While it initially established a presence in the burgeoning cannabis industry, its parent company eventually shifted focus toward consumer food products, leading to the divestment of its hemp assets.